Hyperliquid Strategies Inc (PURR) USD0.0001

Sell:$5.31Buy:$5.33Price decreased$0.02 (0.37%)

Prices delayed by at least 15 minutes
Sell:$5.31
Buy:$5.33
Change:Price decreased$0.02 (0.37%)
Deal now
Prices delayed by at least 15 minutes
Sell:$5.31
Buy:$5.33
Change:Price decreased$0.02 (0.37%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

Key people

Bob Diamond
Chairman of the Board
David Ira Schamis
Chief Executive Officer, Director
Brett Beldner
Chief Financial Officer
Jeroen Nieuwkoop
Chief Operating Officer
Jeff Tuder
Director
Nailesh Bhatt
Independent Director
Albert D. Dyrness
Independent Director
Thomas C. King
Independent Director
Larry Leibowitz
Independent Director
Click to see more

Key facts

  • Shares in issue
    -
  • EPIC
    -
  • ISIN
    US44916Y1064
  • Location
    United States
  • Sector
    Technology
  • Industry
    Computer Services
  • Market cap
    $0.00
  • Employees
    -
  • Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.